Ophthalmic compositions

Details Ophthalmic compositions Ophthalmic compositions

1985-11-01

1990-04-03

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514913, A61K 3156

Patent

active

049140906

ABSTRACT:
The use of an angiotensin converting enzyme inhibitor for reducing and controlling the elevation of intraocular pressure associated with the use of corticosteroids is disclosed. Also disclosed are the use of the combination of an angiotensin converting enzyme inhibitor and a steroid, and pharmaceutical compositions comprising the combination.

REFERENCES:
patent: 3892857 (1975-07-01), Difazio et al.
patent: 3980778 (1976-09-01), Ayer et al.
patent: 4124707 (1978-11-01), Green et al.
patent: 4442089 (1984-04-01), Horovitz
patent: 4472393 (1984-09-01), Shapiro
patent: 4474751 (1984-10-01), Haslam et al.
T. Csaky et al., ed., Cutting's Handbook of Pharmacology, 7th ed. pp. 404-415.
Ann. Rev. Biochem., 51 (1982), 283-308.
M. Wyvratt et al., Medicinal Res. Rev., 5 (1985) pp. 483-531 The Physician's Desk Reference, 1984 ed., p. 998.

Affiliated with

Also associated with

Rating

Ophthalmic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1357709